Opportunities for targeted therapies: trametinib as a therapeutic approach to canine oral squamous cell carcinomas.
Peralta S, Katt W, Balkman C, Butler S, Carney P, Todd-Donato A, Drozd M, Duhamel G, Fiani N, Ford J, Grenier J, Hayward J, Heikinheimo K, Hume K, Moore E, Puri R, Sylvester S, Warshaw S, Webb S, White A, Wright A, Cerione R.
Peralta S, et al. Among authors: duhamel g.
Res Sq [Preprint]. 2024 May 2:rs.3.rs-4289451. doi: 10.21203/rs.3.rs-4289451/v1.
Res Sq. 2024.
PMID: 38746473
Free PMC article.
Preprint.